988235

GlaxoSmithKline LLC — FEI 1035048

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 15, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Durham, NC (United States)

Additional Details

Risk Evaluation and Mitigation Strategies (REMS)